Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia

Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and those with homozygous FH (HoFH) usually require a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Endocrinol Metab (Seoul)
Hoofdauteurs: Tomlinson, Brian, Patil, Nivritti Gajanan, Fok, Manson, Lam, Christopher Wai Kei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean Endocrine Society 2021
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090480/
https://ncbi.nlm.nih.gov/pubmed/33866776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.964
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items